Abstract:Malaria transmission and endemicity in Africa remains hugely disproportionate compared to the rest of the world. The complex life cycle of P. falciparum ( Pf ) between the vertebrate human host and the anopheline vector results in differential expression of genes within and between hosts. An in-depth understanding of Pf interaction with various human genes through regulatory elements will pave way for identification of newer tools in the arsenal for malaria control. Therefore, the regulatory elements (REs) involved in the over- or under-expression of various host immune genes hold the key to elucidating alternative control measures that can be applied for disease surveillance, prompt diagnosis and treatment. We carried out an RNAseq analysis to identify differentially expressed genes and network elucidation of non-coding RNAs and target genes associated with immune response in individuals with different clinical outcomes. Raw RNAseq datasets, retrieved for analyses include individuals with severe (Gambia—20), symptomatic (Burkina Faso—15), asymptomatic (Mali—16) malaria as well as uninfected controls (Tanzania—20; Mali—36). Of the total 107 datasets retrieved, we identified 5534 differentially expressed genes (DEGs) among disease and control groups. A peculiar pattern of DEGs was observed, with individuals presenting with severe/symptomatic malaria having the highest and most diverse upregulated genes, while a reverse phenomenon was recorded among asymptomatic and uninfected individuals. In addition, we identified 141 differentially expressed micro RNA (miRNA), of which 78 and 63 were upregulated and downregulated respectively. Interactome analysis revealed a moderate interaction between DEGs and miRNAs. Of all identified miRNA, five were unique (hsa-mir-32, hsa-mir-25, hsa-mir-221, hsa-mir-29 and hsa-mir-148) because of their connectivity to several genes, including hsa-mir-221 connected to 16 genes. Six-hundred and eight differentially expressed long non coding RNA (lncRNA) were also identified, including SLC7A11, LINC01524 among the upregulated ones. Our study provides important insight into host immune genes undergoing differential expression under different malaria conditions. It also identified unique miRNAs and lncRNAs that modify and/or regulate the expression of various immune genes. These regulatory elements we surmise, have the potential to serve a diagnostic purpose in discriminating between individuals with severe/symptomatic malaria and those with asymptomatic infection or uninfected, following further clinical validation from field isolates.

The malarial blood transcriptome: translational applications

Comparative Transcriptomics and Metabolomics in a Rhesus Macaque Drug Administration Study.

128A Whole-Blood Transcriptional Signature Predicts Parasite Control and Protection from Malaria Fever During Natural Plasmodium Falciparum Infection

Host transcriptional meta-signatures reveal diagnostic biomarkers for Plasmodium falciparum malaria

A Tale of Two Parasites: A Glimpse into the clinical RNA Methylome of P. falciparum and P. vivax isolates

Functional Proteome and Expression Analysis of Sporozoites and Hepatic Stages of Malaria Development

Malaria: biochemical, physiological, diagnostic, and therapeutic updates

Assessment of immune status using blood transcriptomics and potential implications for global health

[Genomic, molecular biology and malaria: new medical perspectives?]

The Human Blood Metabolome-Transcriptome Interface.

Transcriptomic analyses of differentially expressed human genes, micro RNAs and long-non-coding RNAs in severe, symptomatic and asymptomatic malaria infection

Single-cell RNA-seq reveals hidden transcriptional variation in malaria parasites

Refining the transcriptome of the human malaria parasite Plasmodium falciparum using amplification-free RNA-seq

Beyond immunity: a transcriptomic landscape of Plasmodium’s modulation of mosquito metabolic pathways

The Malaria Cell Atlas: Single parasite transcriptomes across the complete Plasmodium life cycle

High throughput human genotyping for variants associated with malarial disease outcomes using custom targeted amplicon sequencing

A fast and cost-effective microsampling protocol incorporating reduced animal usage for time-series transcriptomics in rodent malaria parasites

Genome-wide liver transcriptomic profiling of a malaria mouse model reveals disturbed immune and metabolic responses

Reading the epitranscriptome of the human malaria parasite

From Basic Research to Clinical Applications

Transcriptional Profiles Analysis of COVID-19 and Malaria Patients Reveals Potential Biomarkers in Children